Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Dermira Stock Popped Today

TheMotleyFool

0 0

Shares of Dermira (NASDAQ: DERM), a biopharmaceutical company, jumped at the beginning of today's trading session in response to good news from the Food and Drug Administration. Investors looking forward to a shortened review for the company's experimental eczema therapy drove the stock 9.8% higher as of 12:10 p.m. EST on Tuesday.

Impressive results from a midstage clinical trial persuaded the FDA to give Dermira's eczema candidate lebrikizumab a fast-track designation. Benefits that come with the designation include increased access with regulators before filing a new drug application and a shortened six-month review instead of the standard 10 months.

Image source: Getty Images.

Source Fool.com

Like: 0

DERM

Share